@BTDenominator Do you still have Kulr on your radar? What do you think about the recent news? Could be a nice play especially with the space x IPO coming up
@bottleneckceo@himshouse Bro did you even follow the company the last few years? If you think they only talked and didn't executed like crazy then I don't know what to tell you
We are thrilled to announce we have closed our acquisition of Eucalyptus. We now have the reach to redefine consumer healthcare for hundreds of millions of people across four continents. The next era of consumer health starts now.
More at the link below, including important info:
https://t.co/Ao1DpM2PyA
Wer sagt $HIMS hat keinen Wettbewerbsvorteil, der schaut bewusst weg.
Denn $HIMS hat 7 Wettbewerbsvorteile, die viele ignorieren:
1) Proprietäre Patientendaten von 2,5+ Mio. Abonnenten. Inklusive At-Home-Bluttests und bald auch Einbindung von Wearables.
2) Alles unter einem Dach: Arzt berät, Apotheke produziert, Lieferung an die Haustür. Günstiger für Selbstzahler. (Stichwort: VIMPRO)
3) Eigene Apotheken & Lager senken die Kosten mit jedem neuen Kunden. Ergebnis: 50% D2C-Telemedizin-Marktanteil in den USA.
4) KI-System MedMatch lernt mit jedem Patienten still im Hintergrund: mehr Daten, bessere Behandlungen, stärkere Plattform.
5) Über 60% der $HIMS Kunden nutzen personalisierte Angebote. Warum da noch wechseln?
6) Eine Marke, die aus Tabuthemen tatsächlich Lifestyle macht. Das Kundenerlebnis erinnert sogar an $AAPL.
7) Ein Team über 9 Jahre aufgebaut das Konkurrenten nicht replizieren können. $AMZN ist schon 3 Mal daran gescheitert.
👉 Wer hat mehr Chancen im Gesundheitsmarkt: $HIMS oder $AMZN?
Vollständige Analyse 👇
🚨 BREAKING: $HIMS PARTNERS WITH PRENUVO AND EIGHT SLEEP, INTRODUCES "HIMS & HERS BENEFITS"
- Provides subscribers access to discounts from health partners Prenuvo and Eight Sleep
- The beginning of a larger benefits program
- $400 off a Prenuvo Whole Body Scan
- $350 off on the Eight Sleep Pod 5 series
- CPO Dheerja Kaur quoted in press release 🔥🔥🔥
🚨 BREAKING: $HIMS AND $NVO END FEUD
$HIMS WILL SELL NOVO'S BRANDED GLP-1s ON PLATFORM AGAIN
SOURCE SPOKE ON CONDITION OF ANONYMITY
TO BE FORMALLY ANNOUNCED AS SOON AS MONDAY
SOURCE: BLOOMBERG (@G0INGMAD)
Every choice we make at Hims & Hers is in the pursuit of a single goal: help more people feel great.
It sounds simple, but our current healthcare industry makes it nearly impossible. It’s why more than 2.5M subscribers depend on us for a new experience. One where they’re treated like a person, instead of a patient.
Our Q4 and full year 2025 results are live and they are proof that when you put people at the center of health, more people want to engage. Here’s what to know:
- We’re growing. Hers is expected to eclipse $1B in revenue this year. Hims revenue grew nearly 30% year-over-year. We launched 3 new offerings in 3 months. And we're focused on scaling global key markets to expand access to high-quality care, which we believe will help us reach $1B in international annual revenue by 2030. Across new markets and new specialties, our business has never encompassed this many new high-impact verticals with the potential to exceed $100M in annual revenue.
- We’re more than any one treatment. Since our founding, people have pigeon-holed us based on specific categories. We’ve been known as a hair loss company. An ED company. Today, some may think of us as a GLP-1 company. The reality is that only a small minority of our subscribers are using a compounded GLP-1 treatment. While the cultural conversation changes over time, our value to customers remains the same. Weight Loss is proof of the power of our model and we believe that power is what defines our platform for millions.
- We’re creating a new era of consumer health. We see a future where people benefit from innovations in diagnostics, wearables, and data. Where AI can use that data to define and refine treatments and support clinical guidance. And where verticalized infrastructure more efficiently delivers personalized treatments. The first two pillars – stronger technology and deeper data – are advancing across the industry. We believe that innovation demands the third pillar: a scalable way to make the final step in healthcare more precise and more personal. We’re investing in our capabilities in all three.
Change is coming to healthcare. More on the progress we made this year here: https://t.co/L2V2hdlQNg
Important info here: https://t.co/KFmOZwNahF
BREAKING: since my last post on the gram is BANNED I’m giving away 0.11 BTC to 11 lucky winner that share the post, like it and comment something related 🚨😘😁
rules:
1) no spam
2) no wallets posted
3) no bots or fake accounts
resolution in 24h, private dm on insta
🌏We’re continuing our global expansion!
Today, we’re announcing that we’ve agreed to acquire Eucalyptus, an international leader in consumer health. With this deal, we believe we’re on the path to becoming the leading global consumer health platform, where everyone can access the best care for their needs, regardless of where they live.
Healthcare challenges are global, and solving them looks different for everyone. We can’t wait to work together to bring a local approach to a global problem.
More at the link below ⬇️
https://t.co/GITiw1it9z
@kian_sasan@elonmusk@premium@uvd99 Probably it's censored because they don't want changes in the monetary systeme. They wanna keep people down and want to steal money from people through printing new money / inflation